Table 3.
Relative risk of disease-free survival (DFS).
| Characteristics | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| aHR (95% CI) | p-Value | aHR (95% CI) | p-Value | |
| Age, years | ||||
| ≤65 | Reference | Reference | ||
| >65 | 1.49 (0.91–2.46) | 0.116 | – | 0.756 |
| Sex | ||||
| Male | Reference | Reference | ||
| Female | 0.91 (0.43–1.92) | 0.807 | – | 0.998 |
| BMI, kg/m2 | ||||
| ≤24 | Reference | Reference | ||
| >24 | 0.65 (0.38–1.10) | 0.109 | – | 0.686 |
| CCI | ||||
| ≤2 | Reference | Reference | ||
| >2 | 0.82 (0.49–1.37) | 0.458 | – | 0.084 |
| T stage | ||||
| T1 | Reference | Reference | ||
| T2 | 4.11 (1.72–9.83) | 0.001 | 3.99 (1.67–9.54) | 0.002 |
| T3 | 6.72 (2.96–15.21) | <0.001 | 5.92 (2.61–13.47) | <0.001 |
| T4 | 9.94 (4.35–22.71) | <0.001 | 8.06 (3.51–18.53) | <0.001 |
| N stage | ||||
| N0 | Reference | Reference | ||
| N+ | 3.76 (2.21–6.41) | <0.001 | – | 0.091 |
| M stage | ||||
| M0 | Reference | Reference | ||
| M1 | 3.53 (1.41–8.83) | 0.007 | – | 0.062 |
| Grade | ||||
| Low grade | Reference | Reference | ||
| High grade | 2.03 (0.64–6.52) | 0.232 | – | 0.878 |
| LCR | ||||
| Low | Reference | Reference | 0.002 | |
| High | 0.31 (0.19–0.51) | <0.001 | 0.40 (0.24–0.66) | <0.001 |
BMI, body mass index; aHR, adjusted hazard ratio; LCR, lymphocyte–C-reactive protein ratio; CCI, comprehensive complication index.